S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
US Dollar Replaced By "Biden Bucks"? (Ad)
Why Invest in High-Yield Dividend Stocks?
3 Stable Growth Stocks for Bumpy Times
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
URGENT: Sell these stocks by September 13th (Ad)pixel
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Closing prices for crude oil, gold and other commodities
URGENT: Sell these stocks by September 13th (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
US Dollar Replaced By "Biden Bucks"? (Ad)
Why Invest in High-Yield Dividend Stocks?
3 Stable Growth Stocks for Bumpy Times
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
URGENT: Sell these stocks by September 13th (Ad)pixel
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Closing prices for crude oil, gold and other commodities
URGENT: Sell these stocks by September 13th (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
US Dollar Replaced By "Biden Bucks"? (Ad)
Why Invest in High-Yield Dividend Stocks?
3 Stable Growth Stocks for Bumpy Times
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
URGENT: Sell these stocks by September 13th (Ad)pixel
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Closing prices for crude oil, gold and other commodities
URGENT: Sell these stocks by September 13th (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
US Dollar Replaced By "Biden Bucks"? (Ad)
Why Invest in High-Yield Dividend Stocks?
3 Stable Growth Stocks for Bumpy Times
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
URGENT: Sell these stocks by September 13th (Ad)pixel
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Closing prices for crude oil, gold and other commodities
URGENT: Sell these stocks by September 13th (Ad)pixel
TSE:TRL

Trilogy International Partners - TRL Stock Forecast, Price & News

C$0.22
-0.01 (-4.35%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
C$0.22
C$0.22
50-Day Range
C$0.20
C$2.05
52-Week Range
C$0.16
C$2.77
Volume
11,405 shs
Average Volume
65,073 shs
Market Capitalization
C$18.88 million
P/E Ratio
N/A
Dividend Yield
845.00%
Price Target
C$2.50
TRL stock logo

About Trilogy International Partners (TSE:TRL) Stock

Trilogy International Partners Inc., together with its subsidiaries, provides wireless voice and data communications services in New Zealand, Bolivia, and internationally. It offers prepaid and postpaid payment plans, including local, international long distance, and roaming services to customers and international visitors roaming on its networks. The company also provides fixed broadband communications to residential and enterprise customers, as well as a range of mobile and fixed line services in New Zealand and Australia; and fixed public telephony and wireless broadband services in Bolivia. As of December 31, 2021, it had a distribution network of approximately 13 company owned stores, 170 dealers, and 8,300 other dealer points of presence in Bolivia; and a distribution network of approximately 20 company owned retail stores, 40 independent dealers, and 2,500 points of sale through national retail chains and grocery stores in New Zealand. The company's services cover an aggregate population of 16.8 million users. It also provides services through its online self-service store in New Zealand; and operates under the Viva brand name in Bolivia. Trilogy International Partners Inc. was founded in 1982 and is headquartered in Bellevue, Washington.

Trilogy International Partners Stock Performance

Shares of Trilogy International Partners stock opened at C$0.22 on Friday. The firm has a 50-day moving average of C$0.83 and a 200-day moving average of C$1.64. The stock has a market cap of C$18.88 million and a PE ratio of -0.08. Trilogy International Partners has a 52-week low of C$0.16 and a 52-week high of C$2.77.

Trilogy International Partners (TSE:TRL - Get Rating) last announced its earnings results on Tuesday, May 10th. The specialty pharmaceutical company reported C($0.43) earnings per share (EPS) for the quarter. The firm had revenue of C$196.80 million for the quarter. Equities research analysts predict that Trilogy International Partners will post -0.44 earnings per share for the current fiscal year.

Receive TRL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trilogy International Partners and its competitors with MarketBeat's FREE daily newsletter.

TRL Stock News Headlines

Trilogy International Partners Inc. (TLLYF)
IIROC Trading Halt - TRL.WT
Stocks in play: Trilogy International Partners Inc.
Trilogy International Partners Inc.
News for Trilogy International Partners Inc Registered Shs
See More Headlines
Receive TRL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trilogy International Partners and its competitors with MarketBeat's FREE daily newsletter.

TRL Company Calendar

Today
8/11/2022
Next Earnings (Estimated)
11/08/2022

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Web
N/A
Fax
N/A
Employees
1,622
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$2.50
High Stock Price Forecast
C$2.50
Low Stock Price Forecast
C$2.50
Forecasted Upside/Downside
+1,036.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$639.59 million
Cash Flow
C$0.63 per share
Book Value
C($3.60) per share

Miscellaneous

Free Float
N/A
Market Cap
C$18.88 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. John William Stanton B.A. (Age 67)
    BA, M.B.A., MBA, Co-Founder & Chairman
  • Mr. Bradley Jay Horwitz (Age 66)
    Co-Founder, Pres, CEO & Non-Independent Director
    Comp: $772.15k
  • Ms. Theresa E. Gillespie (Age 69)
    Co-Founder & Non-Independent Director
  • Mr. Erik Mickels CPA
    Sr. VP & CFO
  • Mr. Scott Morris
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Mr. Mark Aue
    Chief Exec. Officer of 2degrees
  • Ms. Ann Saxton
    VP of Investor Relations & Corp. Devel.
  • Mr. Juan Pablo Calvo
    Pres of Nuevatel













TRL Stock - Frequently Asked Questions

Should I buy or sell Trilogy International Partners stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trilogy International Partners in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" TRL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRL, but not buy additional shares or sell existing shares.
View TRL analyst ratings
or view top-rated stocks.

What is Trilogy International Partners' stock price forecast for 2022?

1 analysts have issued 1-year target prices for Trilogy International Partners' shares. Their TRL share price forecasts range from C$2.50 to C$2.50. On average, they predict the company's stock price to reach C$2.50 in the next twelve months. This suggests a possible upside of 1,036.4% from the stock's current price.
View analysts price targets for TRL
or view top-rated stocks among Wall Street analysts.

How have TRL shares performed in 2022?

Trilogy International Partners' stock was trading at C$2.38 on January 1st, 2022. Since then, TRL shares have decreased by 90.8% and is now trading at C$0.22.
View the best growth stocks for 2022 here
.

When is Trilogy International Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our TRL earnings forecast
.

Is Trilogy International Partners a good dividend stock?

Trilogy International Partners (TSE:TRL) pays an annual dividend of C$1.69 per share and currently has a dividend yield of 845.00%. TRL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for TRL.

What other stocks do shareholders of Trilogy International Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trilogy International Partners investors own include Acerus Pharmaceuticals (ASP), Emera (EMA), Merck & Co., Inc. (MRK), (ONCYF) (ONCYF), AxoGen (AXGN), A and W Revenue Royalties Income Fund (AW.UN), ATS Automation Tooling Systems (ATA), Algonquin Power & Utilities (AQN) and Apptio (APTI).

What is Trilogy International Partners' stock symbol?

Trilogy International Partners trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TRL."

How do I buy shares of Trilogy International Partners?

Shares of TRL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Trilogy International Partners' stock price today?

One share of TRL stock can currently be purchased for approximately C$0.22.

How much money does Trilogy International Partners make?

Trilogy International Partners (TSE:TRL) has a market capitalization of C$18.88 million and generates C$639.59 million in revenue each year.

How many employees does Trilogy International Partners have?

The company employs 1,622 workers across the globe.

How can I contact Trilogy International Partners?

Trilogy International Partners' mailing address is Bellevue Wa PO Box 1988, BELLEVUE, WA 98009-1988, United States. The specialty pharmaceutical company can be reached via phone at +1-425-4585900.

This page (TSE:TRL) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.